| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311764 | Urology | 2005 | 7 Pages |
Abstract
The results of this 6-month real life practice study suggest that prior AUR and symptom deterioration during treatment with alfuzosin 10 mg once-daily (IPSS worsening of 4 or more points, bother score greater than 3) were the strongest predictors of AUR and AUR/BPH-related surgery in men with lower urinary tract symptoms.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mark Emberton, Mostafa Elhilali, Haim Matzkin, Niels Harving, Jeroen van Moorselaar, Rudolf Hartung, Antonio Alcaraz, Guy Vallancien, Alf-One Study Group Alf-One Study Group,